HIGHLIGHTS
- who: Kasia Stepniewska from the Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK have published the Article: Safety of single-dose primaquine as a, in the Journal: (JOURNAL) of 01/01/2007
- what: Studies included in this analysis . Most participants in this analysis had a nadir in haemoglobin concentration on days 2 or 3 following the first ACT dose. The authors aimed to determine the incidence of adverse events (AEs), including serious AEs (SAEs), blood transfusions, AEs of grade 2 and above (within 7 and 28 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.